
LINK . SPRINGER . COM {
}
Title:
Prognostic Factors for Breast Cancer: an Immunomorphological Update | Pathology & Oncology Research
Description:
The prognostic variability recorded within homogeneous groups of patients for anatomo-clinical disease stages has led to a more detailed biological characterization of breast cancer. Recently, the attention of the scientific community has focused on the role of tumor-infiltrating lymphocytes (TILs). Therefore, the need of an in-depth immunomorphological characterization of TILs has been emerged. The presence of TILs has been retrospectively investigated in 113 female cases of ductal carcinoma. An immunohistochemical investigation with CD3, CD4, CD8, CD20, CD56, granulysin, perforin-1, granzyme-B and TIA-1 was performed according to the standard procedures on all 17 cases with TILs evidence. TILs consisted of T and B lymphocytes: the prevalent population showed a T immunoprofile with a CD8-immunopositive killer subpopulation (Tk), close-linked to carcinomatous cells, and a CD4-immunopositive helper subpopulation (Th), inside the tumor. A time sequence (firstly T, then B) has been disclosed. Granulysin, perforin, granzyme-B and TIA-1 were expressed by Tk cells. The activated Tk cells secrete these mediators as a result of the binding to the tumor target cell, causing its lytic planned death. The cytotoxicity supported by Tk cells appears an important favorable prognostic factor. Therefore, a graduation system for TILs in breast cancer has been here proposed (absent, non-brisk, brisk).
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {๐}
- Health & Fitness
- Science
- Education
Content Management System {๐}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {๐}
What is the average monthly size of link.springer.com audience?
๐ Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,734,772 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {๐ธ}
We can't see how the site brings in money.
Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.
Keywords {๐}
cancer, article, breast, pubmed, google, scholar, lymphocytes, prognostic, cas, tumorinfiltrating, tumor, roncati, tils, cells, central, research, privacy, cookies, content, barbolini, access, infiltrating, health, publish, search, pathology, luca, primary, predictive, modena, data, information, log, journal, oncology, factors, immunomorphological, november, piacentini, disease, ductal, carcinoma, granulysin, tia, cell, factor, response, chapter, discover, cytotoxic,
Topics {โ๏ธ}
fas-activated serine/threonine kinase tumour-infiltrating cd8+ lymphocytes month download article/chapter triple-negative breast cancer francesco piscioliย &ย teresa pusiol small-cell lung cancer node-negative breast cancer cd8-immunopositive killer subpopulation cd4-immunopositive helper subpopulation tumor-infiltrating immune cells anatomo-clinical disease stages jak2/stat4/perforin pathway breast tumor growth full article pdf tumor-infiltrating lymphocytes tumor infiltrating lymphocytes tumor target cell prognostic factors independent predictive factor privacy choices/manage cookies early breast cancer breast cancer treated breast cancer subtypes human breast cancer favorable prognostic marker primary systemic therapy prognostic variability recorded fas-mediated apoptosis invasive tumor front infiltrating ductal carcinoma article roncati depth immunomorphological characterization european economic area detailed biological characterization prevalent population showed lytic planned death related subjects evaluating jak2 inhibitors cryptotanshinone induces inhibition ethics declarations funding conditions privacy policy cytotoxic cd4+ article log tk cells appears neoadjuvant systemic therapy breast cancer accepting optional cookies pathological complete response federico piacentini article cite
Schema {๐บ๏ธ}
WebPage:
mainEntity:
headline:Prognostic Factors for Breast Cancer: an Immunomorphological Update
description:The prognostic variability recorded within homogeneous groups of patients for anatomo-clinical disease stages has led to a more detailed biological characterization of breast cancer. Recently, the attention of the scientific community has focused on the role of tumor-infiltrating lymphocytes (TILs). Therefore, the need of an in-depth immunomorphological characterization of TILs has been emerged. The presence of TILs has been retrospectively investigated in 113 female cases of ductal carcinoma. An immunohistochemical investigation with CD3, CD4, CD8, CD20, CD56, granulysin, perforin-1, granzyme-B and TIA-1 was performed according to the standard procedures on all 17 cases with TILs evidence. TILs consisted of T and B lymphocytes: the prevalent population showed a T immunoprofile with a CD8-immunopositive killer subpopulation (Tk), close-linked to carcinomatous cells, and a CD4-immunopositive helper subpopulation (Th), inside the tumor. A time sequence (firstly T, then B) has been disclosed. Granulysin, perforin, granzyme-B and TIA-1 were expressed by Tk cells. The activated Tk cells secrete these mediators as a result of the binding to the tumor target cell, causing its lytic planned death. The cytotoxicity supported by Tk cells appears an important favorable prognostic factor. Therefore, a graduation system for TILs in breast cancer has been here proposed (absent, non-brisk, brisk).
datePublished:2015-11-20T00:00:00Z
dateModified:2015-11-20T00:00:00Z
pageStart:449
pageEnd:452
sameAs:https://doi.org/10.1007/s12253-015-0024-7
keywords:
Breast cancer
Prognostic factors
Histology
Immunohistochemistry
Tumor-infiltrating lymphocytes (TILs)
Granulysin
Cancer Research
Oncology
Pathology
Immunology
Biomedicine
general
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12253-015-0024-7/MediaObjects/12253_2015_24_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12253-015-0024-7/MediaObjects/12253_2015_24_Fig2_HTML.gif
isPartOf:
name:Pathology & Oncology Research
issn:
1532-2807
1219-4956
volumeNumber:22
type:
Periodical
PublicationVolume
publisher:
name:Springer Netherlands
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Luca Roncati
affiliation:
name:University of Modena and Reggio Emilia, Policlinico Hospital
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
type:PostalAddress
type:Organization
name:Institute of Pathology
address:
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Giuseppe Barbolini
affiliation:
name:University of Modena and Reggio Emilia, Policlinico Hospital
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
type:PostalAddress
type:Organization
type:Person
name:Federico Piacentini
affiliation:
name:University of Modena and Reggio Emilia
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Oncology, University of Modena and Reggio Emilia, Modena, Italy
type:PostalAddress
type:Organization
type:Person
name:Francesco Piscioli
affiliation:
name:Institute of Pathology
address:
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
type:PostalAddress
type:Organization
type:Person
name:Teresa Pusiol
affiliation:
name:Institute of Pathology
address:
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
type:PostalAddress
type:Organization
type:Person
name:Antonio Maiorana
affiliation:
name:University of Modena and Reggio Emilia, Policlinico Hospital
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Prognostic Factors for Breast Cancer: an Immunomorphological Update
description:The prognostic variability recorded within homogeneous groups of patients for anatomo-clinical disease stages has led to a more detailed biological characterization of breast cancer. Recently, the attention of the scientific community has focused on the role of tumor-infiltrating lymphocytes (TILs). Therefore, the need of an in-depth immunomorphological characterization of TILs has been emerged. The presence of TILs has been retrospectively investigated in 113 female cases of ductal carcinoma. An immunohistochemical investigation with CD3, CD4, CD8, CD20, CD56, granulysin, perforin-1, granzyme-B and TIA-1 was performed according to the standard procedures on all 17 cases with TILs evidence. TILs consisted of T and B lymphocytes: the prevalent population showed a T immunoprofile with a CD8-immunopositive killer subpopulation (Tk), close-linked to carcinomatous cells, and a CD4-immunopositive helper subpopulation (Th), inside the tumor. A time sequence (firstly T, then B) has been disclosed. Granulysin, perforin, granzyme-B and TIA-1 were expressed by Tk cells. The activated Tk cells secrete these mediators as a result of the binding to the tumor target cell, causing its lytic planned death. The cytotoxicity supported by Tk cells appears an important favorable prognostic factor. Therefore, a graduation system for TILs in breast cancer has been here proposed (absent, non-brisk, brisk).
datePublished:2015-11-20T00:00:00Z
dateModified:2015-11-20T00:00:00Z
pageStart:449
pageEnd:452
sameAs:https://doi.org/10.1007/s12253-015-0024-7
keywords:
Breast cancer
Prognostic factors
Histology
Immunohistochemistry
Tumor-infiltrating lymphocytes (TILs)
Granulysin
Cancer Research
Oncology
Pathology
Immunology
Biomedicine
general
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12253-015-0024-7/MediaObjects/12253_2015_24_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12253-015-0024-7/MediaObjects/12253_2015_24_Fig2_HTML.gif
isPartOf:
name:Pathology & Oncology Research
issn:
1532-2807
1219-4956
volumeNumber:22
type:
Periodical
PublicationVolume
publisher:
name:Springer Netherlands
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Luca Roncati
affiliation:
name:University of Modena and Reggio Emilia, Policlinico Hospital
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
type:PostalAddress
type:Organization
name:Institute of Pathology
address:
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Giuseppe Barbolini
affiliation:
name:University of Modena and Reggio Emilia, Policlinico Hospital
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
type:PostalAddress
type:Organization
type:Person
name:Federico Piacentini
affiliation:
name:University of Modena and Reggio Emilia
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Oncology, University of Modena and Reggio Emilia, Modena, Italy
type:PostalAddress
type:Organization
type:Person
name:Francesco Piscioli
affiliation:
name:Institute of Pathology
address:
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
type:PostalAddress
type:Organization
type:Person
name:Teresa Pusiol
affiliation:
name:Institute of Pathology
address:
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
type:PostalAddress
type:Organization
type:Person
name:Antonio Maiorana
affiliation:
name:University of Modena and Reggio Emilia, Policlinico Hospital
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Pathology & Oncology Research
issn:
1532-2807
1219-4956
volumeNumber:22
Organization:
name:Springer Netherlands
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:University of Modena and Reggio Emilia, Policlinico Hospital
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
type:PostalAddress
name:Institute of Pathology
address:
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
type:PostalAddress
name:University of Modena and Reggio Emilia, Policlinico Hospital
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
type:PostalAddress
name:University of Modena and Reggio Emilia
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Oncology, University of Modena and Reggio Emilia, Modena, Italy
type:PostalAddress
name:Institute of Pathology
address:
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
type:PostalAddress
name:Institute of Pathology
address:
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
type:PostalAddress
name:University of Modena and Reggio Emilia, Policlinico Hospital
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Luca Roncati
affiliation:
name:University of Modena and Reggio Emilia, Policlinico Hospital
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
type:PostalAddress
type:Organization
name:Institute of Pathology
address:
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
type:PostalAddress
type:Organization
email:[email protected]
name:Giuseppe Barbolini
affiliation:
name:University of Modena and Reggio Emilia, Policlinico Hospital
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
type:PostalAddress
type:Organization
name:Federico Piacentini
affiliation:
name:University of Modena and Reggio Emilia
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Oncology, University of Modena and Reggio Emilia, Modena, Italy
type:PostalAddress
type:Organization
name:Francesco Piscioli
affiliation:
name:Institute of Pathology
address:
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
type:PostalAddress
type:Organization
name:Teresa Pusiol
affiliation:
name:Institute of Pathology
address:
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
type:PostalAddress
type:Organization
name:Antonio Maiorana
affiliation:
name:University of Modena and Reggio Emilia, Policlinico Hospital
address:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Oncology, University of Modena and Reggio Emilia, Modena, Italy
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {๐}(87)
- What is the earnings of https://www.springernature.com/gp/authors?
- Learn how profitable https://link.springernature.com/home/ is on a monthly basis
- Monthly income for https://order.springer.com/public/cart
- Discover the revenue of https://www.springernature.com/gp/librarians/licensing/agc/journals
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Enquete%20permanent%20dans%20les%20centres%20antercancereux&journal=Bull%20Inst%20Hyg&volume=1&publication_year=1946&author=Denoix%2CPF
- What's the revenue for https://doi.org/10.4103%2F0019-509X.118744?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24061465
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Presence%20of%20CD3%2B%20tumor%20infiltrating%20lymphocytes%20is%20significantly%20associated%20with%20good%20prognosis%20in%20infiltrating%20ductal%20carcinoma%20of%20breast&journal=Indian%20J%20Cancer&doi=10.4103%2F0019-509X.118744&volume=50&pages=239-244&publication_year=2013&author=Rathore%2CAS&author=Kumar%2CS&author=Konwar%2CR&author=Srivastava%2CAN&author=Makker%2CA&author=Goel%2CMM?
- See how much https://doi.org/10.1093%2Fannonc%2Fmdu112 makes per month
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24608200 have monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor%20infiltrating%20lymphocytes%20are%20prognostic%20in%20triple%20negative%20breast%20cancer%20and%20predictive%20for%20trastuzumab%20benefit%20in%20early%20breast%20cancer%3A%20results%20from%20the%20FinHER%20trial&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdu112&volume=25&pages=1544-1550&publication_year=2014&author=Loi%2CS&author=Michiels%2CS&author=Salgado%2CR&author=Sirtaine%2CN&author=Jose%2CV&author=Fumagalli%2CD make?
- What's the income of https://doi.org/10.1093%2Fannonc%2Fmdt556?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24401929
- What's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933248?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Prognostic%20value%20of%20tumor-infiltrating%20lymphocytes%20on%20residual%20disease%20after%20primary%20chemotherapy%20for%20triple-negative%20breast%20cancer%3A%20a%20retrospective%20multicenter%20study&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdt556&volume=25&pages=611-618&publication_year=2014&author=Dieci%2CMV&author=Criscitiello%2CC&author=Goubar%2CA&author=Viale%2CG&author=Conte%2CP&author=Guarneri%2CV earns monthly
- Learn about the earnings of https://doi.org/10.1158%2F2326-6066.CIR-13-0189
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24764577's earnings
- What are the total earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001121?
- Earnings of http://scholar.google.com/scholar_lookup?&title=JAK2%20expression%20is%20associated%20with%20tumor-infiltrating%20lymphocytes%20and%20improved%20breast%20cancer%20outcomes%3A%20implications%20for%20evaluating%20JAK2%20inhibitors&journal=Cancer%20Immunol%20Res&doi=10.1158%2F2326-6066.CIR-13-0189&volume=2&pages=301-306&publication_year=2014&author=Miller%2CCP&author=Thorpe%2CJD&author=Kortum%2CAN&author=Coy%2CCM&author=Cheng%2CWY&author=Ou%20Yang%2CTH
- Financial intake of https://doi.org/10.1038%2Fbjc.2013.634
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24129232?
- Get to know http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833219's earnings
- Revenue of http://scholar.google.com/scholar_lookup?&title=Tumour-infiltrating%20CD8%2B%20lymphocytes%20as%20an%20independent%20predictive%20factor%20for%20pathological%20complete%20response%20to%20primary%20systemic%20therapy%20in%20breast%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.2013.634&volume=109&pages=2705-2713&publication_year=2013&author=Seo%2CAN&author=Lee%2CHJ&author=Kim%2CEJ&author=Kim%2CHJ&author=Jang%2CMH&author=Lee%2CHE
- What's the total monthly financial gain of https://doi.org/10.1371%2Fjournal.pone.0095475?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24743335
- Explore the financials of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990637
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Intratumoral%20CD8%2B%20cytotoxic%20lymphocyte%20is%20a%20favorable%20prognostic%20marker%20in%20node-negative%20breast%20cancer&journal=PLoS%20One&doi=10.1371%2Fjournal.pone.0095475&volume=9&publication_year=2014&author=Chen%2CZ&author=Chen%2CX&author=Zhou%2CE&author=Chen%2CG&author=Qian%2CK&author=Wu%2CX
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24596349
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Predictive%20and%20prognostic%20significance%20of%20tumor-infiltrating%20lymphocytes%20in%20patients%20with%20breast%20cancer%20treated%20with%20neoadjuvant%20systemic%20therapy&journal=Anticancer%20Res&volume=34&pages=1115-1125&publication_year=2014&author=Melichar%2CB&author=%C5%A0tudentova%2CH&author=Kal%C3%A1bov%C3%A1%2CH&author=Vit%C3%A1skov%C3%A1%2CD&author=%C4%8Cerm%C3%A1kov%C3%A1%2CP&author=Hornychov%C3%A1%2CH bring in?
- How much income does https://doi.org/10.4161%2Fonci.24720 have?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24073365
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782009 make?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Tumor-infiltrating%20lymphocytes%2C%20breast%20cancer%20subtypes%20and%20therapeutic%20efficacy&journal=Oncoimmunology&doi=10.4161%2Fonci.24720&volume=2&publication_year=2013&author=Loi%2CS?
- How much profit does https://doi.org/10.1073%2Fpnas.1104303108 generate?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21825174 generate?
- Find out how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287000 earns monthly
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Leukocyte%20composition%20of%20human%20breast%20cancer&journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&doi=10.1073%2Fpnas.1104303108&volume=109&pages=2796-2801&publication_year=2012&author=Ruffell%2CB&author=Au%2CA&author=Rugo%2CHS&author=Esserman%2CLJ&author=Hwang%2CES&author=Coussens%2CLM
- How much cash flow does https://doi.org/10.1136%2Fjcp.2005.031252 have monthly?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16935972
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1860493 gross monthly?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20the%20mononuclear%20inflammatory%20cell%20infiltrate%20in%20the%20normal%20breast%2C%20benign%20proliferative%20breast%20disease%2C%20in%20situ%20and%20infiltrating%20ductal%20breast%20carcinomas%3A%20preliminary%20observations&journal=J%20Clin%20Pathol&doi=10.1136%2Fjcp.2005.031252&volume=59&pages=972-977&publication_year=2006&author=Hussein%2CMR&author=Hassan%2CHI
- What's the profit of https://doi.org/10.1084%2Fjem.182.3.865?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7544399's earnings
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Fas-activated%20serine%2Fthreonine%20kinase%20%28FAST%29%20phosphorylates%20TIA-1%20during%20Fas-mediated%20apoptosis&journal=J%20Exp%20Med&doi=10.1084%2Fjem.182.3.865&volume=182&pages=865-874&publication_year=1995&author=Tian%2CQ&author=Taupin%2CJ&author=Elledge%2CS&author=Robertson%2CM&author=Anderson%2CP bring in?
- Find out how much https://doi.org/10.7314%2FAPJCP.2014.15.6.2439 earns monthly
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24761844?
- Get to know http://scholar.google.com/scholar_lookup?&title=Cryptotanshinone%20induces%20inhibition%20of%20breast%20tumor%20growth%20by%20cytotoxic%20CD4%2B%20T%20cells%20through%20the%20JAK2%2FSTAT4%2Fperforin%20pathway&journal=Asian%20Pac%20J%20Cancer%20Prev&doi=10.7314%2FAPJCP.2014.15.6.2439&volume=15&pages=2439-2445&publication_year=2014&author=Zhou%2CJ&author=Xu%2CXZ&author=Hu%2CYR&author=Hu%2CAR&author=Zhu%2CCL&author=Gao%2CGS's earnings
- http://scholar.google.com/scholar_lookup?&title=Vascular%20endothelial%20growth%20factor%2Freceptor%20systems%20expressed%20by%20basophils%20in%20vaginal%20angiomyofibroblastoma&journal=Pathologica&volume=102&publication_year=2010&author=Roncati%2CL&author=Barbolini%2CG&author=Rivasi%2CF income
- What's the revenue for https://doi.org/10.1309%2FG6EK-Y6EH-0LGY-6D6P?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11392882?
- How much does http://scholar.google.com/scholar_lookup?&title=Histologic%20classification%20of%20tumor-infiltrating%20lymphocytes%20in%20primary%20cutaneous%20malignant%20melanoma.%20A%20study%20of%20interobserver%20agreement&journal=Am%20J%20Clin%20Pathol&doi=10.1309%2FG6EK-Y6EH-0LGY-6D6P&volume=115&pages=856-860&publication_year=2001&author=Busam%2CKJ&author=Antonescu%2CCR&author=Marghoob%2CAA&author=Nehal%2CKS&author=Sachs%2CDL&author=Shia%2CJ make?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15660281
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Immunophenotype%20of%20lymphocytic%20infiltration%20in%20medullary%20carcinoma%20of%20the%20breast&journal=Virchows%20Arch&doi=10.1007%2Fs00428-004-1143-9&volume=446&pages=10-14&publication_year=2005&author=Kuroda%2CH&author=Tamaru%2CJ&author=Sakamoto%2CG&author=Ohnisi%2CK&author=Itoyama%2CS?
- https://doi.org/10.17795%2Fgct-20330's total income per month
- How much profit does http://scholar.google.com/scholar_lookup?&title=Absence%20of%20immune%20response%20as%20a%20sign%20of%20tissue%20tolerance%20in%20small-cell%20lung%20cancer&journal=Gene%20Cell%20Tissue&doi=10.17795%2Fgct-20330&volume=1&publication_year=2014&author=Manenti%2CA&author=Roncati%2CL&author=Sighinolfi%2CP&author=Barbolini%2CG make?
- Discover the revenue of https://citation-needed.springer.com/v2/references/10.1007/s12253-015-0024-7?format=refman&flavour=references
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Luca%20Roncati?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Luca%20Roncati%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Giuseppe%20Barbolini each month?
- Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Giuseppe%20Barbolini%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Federico%20Piacentini's total income per month
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Federico%20Piacentini%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Francesco%20Piscioli generate?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Francesco%20Piscioli%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Teresa%20Pusiol earning monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Teresa%20Pusiol%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Antonio%20Maiorana's earnings
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Antonio%20Maiorana%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- What's the monthly income of https://s100.copyright.com/AppDispatchServlet?title=Prognostic%20Factors%20for%20Breast%20Cancer%3A%20an%20Immunomorphological%20Update&author=Luca%20Roncati%20et%20al&contentID=10.1007%2Fs12253-015-0024-7©right=Ar%C3%A1nyi%20Lajos%20Foundation&publication=1219-4956&publicationDate=2015-11-20&publisherName=SpringerNature&orderBeanReset=true?
- What's the financial intake of https://crossmark.crossref.org/dialog/?doi=10.1007/s12253-015-0024-7?
- What is the monthly revenue of https://citation-needed.springer.com/v2/references/10.1007/s12253-015-0024-7?format=refman&flavour=citation?
- How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral pull in monthly?
- Revenue of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- Discover the revenue of https://www.springernature.com/gp/products
- How much does https://www.springernature.com/gp/librarians generate monthly?
- https://www.springernature.com/gp/societies's financial summary
- What's the revenue for https://www.springernature.com/gp/partners?
- Earnings of https://www.springer.com/
- What's the financial intake of https://www.nature.com/?
- How much does https://www.biomedcentral.com/ net monthly?
- How much does https://www.palgrave.com/ bring in each month?
- See how much https://www.apress.com/ makes per month
- https://www.springernature.com/gp/legal/ccpa's revenue stream
- What's the total monthly financial gain of https://www.springernature.com/gp/info/accessibility?
- What's the income generated by https://support.springernature.com/en/support/home each month?
- How much profit is https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations making per month?
- https://www.springernature.com/'s revenue stream
Analytics and Tracking {๐}
- Google Tag Manager
Libraries {๐}
- Clipboard.js
- Prism.js
CDN Services {๐ฆ}
- Crossref